These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32434045)

  • 1. Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan.
    Sun CF; Chiu WC; Chen PC; Chang HC; Guu TW; Shityakov S; Miller AH; Felger JC; Chang JP; Su KP
    Brain Behav Immun; 2020 Aug; 88():125-131. PubMed ID: 32434045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence of depressive disorders after interferon-induced depression.
    Chiu WC; Su YP; Su KP; Chen PC
    Transl Psychiatry; 2017 Feb; 7(2):e1026. PubMed ID: 28170005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder.
    Su KP; Lai HC; Peng CY; Su WP; Chang JP; Pariante CM
    Brain Behav Immun; 2019 Aug; 80():512-518. PubMed ID: 31059806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C.
    Raison CL; Broadwell SD; Borisov AS; Manatunga AK; Capuron L; Woolwine BJ; Jacobson IM; Nemeroff CB; Miller AH
    Brain Behav Immun; 2005 Jan; 19(1):23-7. PubMed ID: 15581735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental Disorders and Interferon Nontreatment in Hepatitis C Virus Infection-a Population Based Cohort Study.
    Chiu WC; Lu ML; Chang CC
    Psychiatry Investig; 2020 Mar; 17(3):268-274. PubMed ID: 32151125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
    Chang YK; Tseng YT; Chen KH; Chen KT
    BMC Endocr Disord; 2019 Apr; 19(1):36. PubMed ID: 30953492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.
    Hsu CS; Kao JH; Chao YC; Lin HH; Fan YC; Huang CJ; Tsai PS
    Aliment Pharmacol Ther; 2013 Aug; 38(4):415-23. PubMed ID: 23802888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression-free after interferon-a exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan.
    Liu PS; Liaw YP
    Brain Behav Immun; 2022 May; 102():88. PubMed ID: 35172189
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
    Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
    J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive disorders among patients with gastric cancer in Taiwan: a nationwide population-based study.
    Hu LY; Liu CJ; Yeh CM; Lu T; Hu YW; Chen TJ; Chen PM; Lee SC; Chang CH
    BMC Psychiatry; 2018 Sep; 18(1):272. PubMed ID: 30176847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
    Sarkar S; Kemper J; Sarkar R; Brants L; Friebe A; Spengler U; Schläpfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Discher T; Zeuzem S; Berg T; Schaefer M
    J Affect Disord; 2021 Sep; 292():766-772. PubMed ID: 34171555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
    Lai CH; Yang YH; Chen PC; King YC; Liu CY
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
    J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.
    Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P
    J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic symptoms in inflammation-related depression: Reply to "Letter for depression-free after interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan".
    Sun CF; Chiu WC; Su KP
    Brain Behav Immun; 2022 May; 102():161-162. PubMed ID: 35172190
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study.
    Chang SC; Hung CT; Li SF; Lee HM; Chung YC; Pai LW; Yang SS
    J Formos Med Assoc; 2015 Sep; 114(9):829-34. PubMed ID: 24090634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
    Hsu YC; Lin JT; Ho HJ; Kao YH; Huang YT; Hsiao NW; Wu MS; Liu YY; Wu CY
    Hepatology; 2014 Apr; 59(4):1293-302. PubMed ID: 24122848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.